Blog 3 Columns

TSA Medical Marijuana Policy Unchanged Despite Viral Claims 0

Rumors circulating in May 2026 suggested the U.S. Transportation Security Administration (TSA) had updated its rules to allow medical marijuana in both carry-on and checked luggage. However, a Snopes investigation found the claim to be misleading. While the TSA did revise its website in April, removing some references to federal cannabis laws, the agency confirmed its policy

Louisiana Advances Bill Allowing Medical Marijuana Use in Healthcare Facilities 0

Louisiana lawmakers have approved a bill that would permit certain terminally ill patients to use medical marijuana within healthcare facilities, sending the measure to Governor Jeff Landry for final consideration. Senate Bill 270 passed the House 54–44 after previously clearing the Senate with strong support. The proposal applies to patients diagnosed with terminal and irreversible

Georgia Set to Broaden Medical Marijuana Access This Summer 0

Georgia’s tightly controlled medical marijuana program is poised for a major expansion after Gov. Brian Kemp signed Senate Bill 220 into law, with changes taking effect July 1. The measure removes previous caps on THC levels in medical cannabis products and will allow additional forms, including flower and vape cartridges, to be sold to registered

CBD Gummies Gain Momentum in the Wellness Market 0

CBD gummies are rapidly emerging as a popular wellness product, offering a discreet and easy way to consume cannabidiol. Derived from hemp and free from psychoactive effects, these chewable supplements are commonly used to support sleep, stress relief, and recovery. Low-dose CBD products are available over the counter, provided they meet strict standards, including zero

Bohacek Drafts 2027 Bill To Legalize Medical Marijuana In Indiana 0

Indiana State Sen. Mike Bohacek is preparing 2027 legislation that would legalize medical marijuana, citing shifting federal policy and growing openness from Gov. Mike Braun. The proposal follows the Trump administration’s move to reclassify state-licensed medical marijuana as a less-restricted Schedule III drug, a change that recognizes its medical use under federal law. Bohacek’s measure

Medical Marijuana Shift Brings Big Stakes for the Midwest 0

The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that

Medical Marijuana Reclassified, But CBD Rules Largely Unchanged 0
- CANNABIS OIL
- May 5, 2026
Federal drug policy took a notable shift on April 23, when Acting U.S. Attorney General Todd Blanche ordered state-licensed medical marijuana moved from Schedule I to Schedule III, a category reserved for substances with “moderate to low” dependence risk. The change acknowledges growing public support for medical cannabis but stops short of altering federal rules
READ MORE
Alabama Medical Marijuana Launch Delayed Five Years, Now Set for Early May 0
- MEDICAL MARIJUANA
- April 30, 2026
After nearly five years of legislative approval and extensive litigation, Alabama’s medical cannabis program is finally approaching launch. According to Alabama.com, the first biomass was delivered to processors on April 10, with dispensaries expected to open in early to mid-May. Alabama’s program prohibits smokable forms, restricting products to tablets, tinctures, patches, oils, and peach-flavored gummies. The
READ MORE
DOJ Reclassifies Medical Marijuana in ‘Historic’ Policy Shift 0
- MEDICAL MARIJUANA
- April 28, 2026
The U.S. Department of Justice has ordered looser federal regulation of state-legal medical marijuana, in what advocates are calling a “historic” shift in federal drug policy. Under an order signed by acting Attorney General Todd Blanche, many cannabis products will move from Schedule I, the government’s strictest drug category, to Schedule III, aligning them with
READ MORE